Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2014 1
2016 1
2017 3
2018 7
2019 7
2020 15
2021 13
2022 19
2023 19
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, Chien N, Trinh S, Henry L, Stave CD, Hosaka T, Cheung RC, Nguyen MH. Ye Q, et al. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12. Lancet Gastroenterol Hepatol. 2020. PMID: 32413340
BACKGROUND: Although non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, it is increasingly being identified in non-obese individuals. ...Among people with non-obese or lean NALFD, 39.0% (95% CI 24.1-56.3 …
BACKGROUND: Although non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, it is …
Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
Lee D, Chiavaroli L, Ayoub-Charette S, Khan TA, Zurbau A, Au-Yeung F, Cheung A, Liu Q, Qi X, Ahmed A, Choo VL, Blanco Mejia S, Malik VS, El-Sohemy A, de Souza RJ, Wolever TMS, Leiter LA, Kendall CWC, Jenkins DJA, Sievenpiper JL. Lee D, et al. Nutrients. 2022 Jul 12;14(14):2846. doi: 10.3390/nu14142846. Nutrients. 2022. PMID: 35889803 Free PMC article.
Background: Fructose providing excess calories in the form of sugar sweetened beverages (SSBs) increases markers of non-alcoholic fatty liver disease (NAFLD). Whether this effect holds for other important food sources of fructose-containing suga …
Background: Fructose providing excess calories in the form of sugar sweetened beverages (SSBs) increases markers of non-alcoholic …
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Jarvis H, Craig D, Barker R, Spiers G, Stow D, Anstee QM, Hanratty B. Jarvis H, et al. PLoS Med. 2020 Apr 30;17(4):e1003100. doi: 10.1371/journal.pmed.1003100. eCollection 2020 Apr. PLoS Med. 2020. PMID: 32353039 Free PMC article.
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide. ...Databases (including MEDLINE, EMBASE, the Cochrane Library, and ClinicalTrials.gov) were searched up to 9 January 2020. …
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disea …
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis.
Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, Ye Q, Huang DQ, Zhao C, Zhang J, Liu C, Chang N, Xing F, Yan S, Wan ZH, Tang NSY, Mayumi M, Liu X, Liu C, Rui F, Yang H, Yang Y, Jin R, Le RHX, Xu Y, Le DM, Barnett S, Stave CD, Cheung R, Zhu Q, Nguyen MH. Le MH, et al. Clin Gastroenterol Hepatol. 2022 Dec;20(12):2809-2817.e28. doi: 10.1016/j.cgh.2021.12.002. Epub 2021 Dec 7. Clin Gastroenterol Hepatol. 2022. PMID: 34890795
BACKGROUND & AIMS: The increasing rates of obesity and type 2 diabetes mellitus may lead to increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine the current and recent trends on the global and regional prevalence of NAFL …
BACKGROUND & AIMS: The increasing rates of obesity and type 2 diabetes mellitus may lead to increased prevalence of nonalcoholic fatt …
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
Selvaraj EA, Mózes FE, Jayaswal ANA, Zafarmand MH, Vali Y, Lee JA, Levick CK, Young LAJ, Palaniyappan N, Liu CH, Aithal GP, Romero-Gómez M, Brosnan MJ, Tuthill TA, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Selvaraj EA, et al. J Hepatol. 2021 Oct;75(4):770-785. doi: 10.1016/j.jhep.2021.04.044. Epub 2021 May 13. J Hepatol. 2021. PMID: 33991635 Free article.
BACKGROUND AND AIMS: Vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic resonance elastography (MRE), and magnetic resonance imaging (MRI) have been proposed as non-invasive test …
BACKGROUND AND AIMS: Vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2-dimensional shear wave elas …
Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review.
Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, Zafarmand MH. Lee J, et al. Liver Int. 2021 Feb;41(2):261-270. doi: 10.1111/liv.14669. Liver Int. 2021. PMID: 32946642 Free PMC article.
BACKGROUND & AIMS: Fibrosis is the strongest predictor for long-term clinical outcomes among patients with non-alcoholic fatty liver disease (NAFLD). There is growing interest in employing non-invasive methods for risk stratification …
BACKGROUND & AIMS: Fibrosis is the strongest predictor for long-term clinical outcomes among patients with non-alcoholic …
Association Between Non-alcoholic Fatty Liver Disease and Heavy Metal Exposure: a Systematic Review.
Sadighara P, Abedini AH, Irshad N, Ghazi-Khansari M, Esrafili A, Yousefi M. Sadighara P, et al. Biol Trace Elem Res. 2023 Dec;201(12):5607-5615. doi: 10.1007/s12011-023-03629-9. Epub 2023 Mar 16. Biol Trace Elem Res. 2023. PMID: 36929113 Review.
Non-alcoholic fatty liver disease (NAFLD) is a debilitating disease with adverse effects including cirrhosis and hepatocellular carcinoma. Heavy metals can cause severe dysfunction in different body organs including the liver. This …
Non-alcoholic fatty liver disease (NAFLD) is a debilitating disease with adverse effects including …
LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
Zeng Q, Liu CH, Wu D, Jiang W, Zhang N, Tang H. Zeng Q, et al. Biomolecules. 2023 Mar 20;13(3):560. doi: 10.3390/biom13030560. Biomolecules. 2023. PMID: 36979495 Free PMC article. Review.
Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease worldwide. ...In this systematic review, we highlight the great potential of lncRNA/circRNA for early diagnosis and progre …
Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver d …
Non-alcoholic fatty liver disease is associated with a worse prognosis in patients with heart failure: A pool analysis.
Qiu M, Li J, Hao S, Zheng H, Zhang X, Zhu H, Zhu X, Hu Y, Cai X, Huang Y. Qiu M, et al. Front Endocrinol (Lausanne). 2023 Apr 20;14:1167608. doi: 10.3389/fendo.2023.1167608. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152967 Free PMC article.
BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is associated with a higher risk of heart failure (HF) than those without NAFLD. ...
BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is associated with a higher risk of heart …
Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis.
Sun Q, Zhang T, Manji L, Liu Y, Chang Q, Zhao Y, Ding Y, Xia Y. Sun Q, et al. Clin Epidemiol. 2023 Jun 5;15:683-693. doi: 10.2147/CLEP.S403314. eCollection 2023. Clin Epidemiol. 2023. PMID: 37305378 Free PMC article. Review.
OBJECTIVE: Recent epidemiological evidence shows that there is an association between serum uric acid (SUA) levels and nonalcoholic fatty liver disease (NAFLD). The purpose of this meta-analysis is to summarize all available evidence and assess the associatio …
OBJECTIVE: Recent epidemiological evidence shows that there is an association between serum uric acid (SUA) levels and nonalcoholic fatty …
85 results